More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

Cell-Penetrating Phylomers Improve Delivery of Drugs

Jun 15, 2016 at 12:21 AM EDT · Issued by PYC Therapeutics Limited

Filed with ASX · Jun 15, 2016 at 12:21 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/cell-penetrating-phylomers-improve-delivery-of-drugs

PYC Therapeutics Limited on 6ix

Story so far

  • New Patent to Discover Sophisticated Cell Penetrating DrugsMar 30, 2016
  • Agreement with Major UK company to Build New DrugsFeb 11, 2016

Earlier from PYC Therapeutics

  • R&D Tax RebateMar 30, 2016
  • Phylogica Signs Agreement with MedImmune / AstraZenecaMar 30, 2016
  • Phylogica - New Potential For Treating Brain InjuryMar 30, 2016
  • Phylogica Accesses Novel Half-Life Extension TechnologyMar 30, 2016
  • Technology Licence to Janssen BiotechMar 30, 2016

Later from PYC Therapeutics

  • Chief Executive Officer ResignationJul 18, 2016
  • Operational UpdateJul 27, 2016
  • Shareholder UpdateSep 29, 2016
  • AGM Presentation to ShareholdersNov 25, 2016
  • NHMRC Grant Awarded to CollaboratorsDec 5, 2016
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer